Eugene Shakhnovich, Ph.D.

Eugene Shakhnovich, Ph.D.

Co-founder, Vitae Pharmaceuticals, Inc.
Professor of Chemistry, Harvard University

Dr. Shakhnovich received his M.S. in 1981 in Theoretical Physics from Moscow University. In 1984, he received his Ph.D. in Theoretical Biophysics and Molecular Biology in from the Russian Academy of Sciences. He was a Research Fellow and Senior Research Fellow in the Institute of Protein Research of the then Soviet Academy of Sciences until his arrival to Harvard in 1990, where he held Assistant (1991) and Associate (1995) Professorships. He is now Full Professor of Chemistry, Chemical Biology and Biophysics (since 1997) at Harvard. His research interests include theoretical studies of Protein Folding, Evolution and Design, Rational Drug Design, theory of Complex systems, Bioinformatics and Theoretical Material Science. He is the author of more than 200 publications and a recipient of several awards and fellowships. In 1997, he founded Initio, a company based on SMoG technology. In 2001, Initio merged with Vitae Pharmaceuticals.